These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17301517)

  • 1. New-onset diabetic ketoacidosis induced by the addition of perospirone hydrochloride in a patient treated with risperidone.
    Hamanaka S; Kamijo Y
    Intern Med; 2007; 46(4):199-200. PubMed ID: 17301517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin levels in schizophrenic patients receiving perospirone in comparison to risperidone.
    Togo T; Iseki E; Shoji M; Oyama I; Kase A; Uchikado H; Katsuse O; Kosaka K
    J Pharmacol Sci; 2003 Mar; 91(3):259-62. PubMed ID: 12686750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perospirone in the treatment of patients with delirium.
    Takeuchi T; Furuta K; Hirasawa T; Masaki H; Yukizane T; Atsuta H; Nishikawa T
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):67-70. PubMed ID: 17239041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients.
    Yasui-Furukori N; Furukori H; Sugawara N; Tsuchimine S; Fujii A; Inoue Y; Kaneko S
    Hum Psychopharmacol; 2010 Apr; 25(3):236-42. PubMed ID: 20373475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of "the premonitory state of schizophrenia" with atypical antipsychotics].
    Abekawa T; Kitaichi Y; Matsuyama T; Koyama T
    Seishin Shinkeigaku Zasshi; 2004; 106(11):1357-72. PubMed ID: 15700533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.
    Ramaswamy K; Kozma CM; Nasrallah H
    Drug Saf; 2007; 30(7):589-99. PubMed ID: 17604410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perospirone therapy in elderly patients with schizophrenia].
    Masui T; Honma H; Kondo C; Osawa T; Iwasaki S; Matsubara S
    Seishin Shinkeigaku Zasshi; 2003; 105(10):1247-53. PubMed ID: 14679781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of coprophagia in a patient with schizophrenia with the novel atypical antipsychotic drug perospirone.
    Harada KI; Yamamoto K; Saito T
    Pharmacopsychiatry; 2006 May; 39(3):113. PubMed ID: 16721701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient.
    Lu CH; Yan YH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e66-7. PubMed ID: 19135753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone.
    Sato Y; Yasui-Furukori N; Kaneko S; Moriyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):577-8. PubMed ID: 17919798
    [No Abstract]   [Full Text] [Related]  

  • 12. Perospirone.
    Onrust SV; McClellan K
    CNS Drugs; 2001; 15(4):329-37; discussion 338. PubMed ID: 11463136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
    Mithat B; Alpaslan T; Bulent C; Cengiz T
    Pharmacopsychiatry; 2005 Mar; 38(2):105-6. PubMed ID: 15744639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological characteristics of perospirone hydrochloride, a novel antipsychotic agent].
    Ohno Y
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):225-31. PubMed ID: 11084919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: three case reports.
    Nishida M; Nakamura M
    Int Clin Psychopharmacol; 2004 Jan; 19(1):41-3. PubMed ID: 15101570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of perospirone-induced mania in schizophrenia.
    Yokoshima T; Takei N; Tani K; Kawai M; Minabe Y; Mori N
    J Clin Psychiatry; 2004 Jan; 65(1):135. PubMed ID: 14974495
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
    Henderson DC; Cagliero E; Copeland PM; Louie PM; Borba CP; Fan X; Freudenreich O; Goff DC
    J Clin Psychiatry; 2007 Apr; 68(4):533-41. PubMed ID: 17474808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perospirone (Sumitomo Pharmaceuticals).
    de Paulis T
    Curr Opin Investig Drugs; 2002 Jan; 3(1):121-9. PubMed ID: 12054062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.